Alejandro Vázquez‐Martín
- Molecular Biology top 1%
- Oncology top 1%
- Cancer Research top 0.5%
- Epidemiology top 5%
- Surgery top 5%
- Co-authors
- Javier A. MenéndezCristina Oliveras‐FerrarosSílvia CufíBegoña Martı́n-CastilloJorge JovenRámón ColomerBruna Corominas-FajaSonia Del Barco
- Topics
- Metabolism, Diabetes, and Cancer (29 papers)Cancer, Lipids, and Metabolism (16 papers)HER2/EGFR in Cancer Research (15 papers)
- Partner nations
- SpainAustraliaUnited States
In The Last Decade
Alejandro Vázquez‐Martín
89 papers receiving 6.0k citations
Peers
Comparison fields: 5 of 124
- Molecular Biology 4.1k
- Oncology 2.1k
- Cancer Research 1.8k
- Epidemiology 879
- Surgery 689
Countries citing papers authored by Alejandro Vázquez‐Martín
This map shows the geographic impact of Alejandro Vázquez‐Martín's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Vázquez‐Martín with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Vázquez‐Martín more than expected).
Fields of papers citing papers by Alejandro Vázquez‐Martín
This network shows the impact of papers produced by Alejandro Vázquez‐Martín. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Vázquez‐Martín. The network helps show where Alejandro Vázquez‐Martín may publish in the future.
Co-authorship network of co-authors of Alejandro Vázquez‐Martín
This figure shows the co-authorship network connecting the top 25 collaborators of Alejandro Vázquez‐Martín. A scholar is included among the top collaborators of Alejandro Vázquez‐Martín based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alejandro Vázquez‐Martín. Alejandro Vázquez‐Martín is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 76 | |
| 3 | 104 | |
| 4 | 236 | |
| 5 | 120 | |
| 6 | 68 | |
| 7 | 17 | |
| 8 | 53 | |
| 9 | 117 | |
| 10 | 30 | |
| 11 | 38 | |
| 12 | 52 | |
| 13 | 19 | |
| 14 | 120 | |
| 15 | 15 | |
| 16 | 206 | |
| 17 | 33 | |
| 18 | Pharmacological blockade of fatty acid synthase (FASN) reverses acquired autoresistance to trastuzumab (Herceptin by transcriptionally inhibiting 'HER2 super-expression' occurring in high-dose trastuzumab-conditioned SKBR3/Tzb100 breast cancer cells. | 74 |
| 19 | Fatty acid metabolism in cancer cells: Differential inhibitory effects of epigallocatechin (EGCG) and C75 | 2 |
| 20 | 38 |
About Alejandro Vázquez‐Martín
Alejandro Vázquez‐Martín is a scholar working on Cancer Research, Oncology and Applied Microbiology and Biotechnology, having authored 89 papers that have together received 6.1k indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (29 papers), Cancer, Lipids, and Metabolism (16 papers) and HER2/EGFR in Cancer Research (15 papers). The work is most often cited by research in Cancer Research (1.8k citations), Oncology (2.1k citations) and Molecular Biology (4.1k citations). Alejandro Vázquez‐Martín has collaborated with scholars based in Spain, Australia and United States. Frequent co-authors include Javier A. Menéndez, Cristina Oliveras‐Ferraros, Sílvia Cufí, Begoña Martı́n-Castillo, Jorge Joven, Rámón Colomer, Bruna Corominas-Faja, Sonia Del Barco, Joan Brunet and Luciano Vellón. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.